205 related articles for article (PubMed ID: 18633616)
21. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
Dearden CE; Johnson R; Pettengell R; Devereux S; Cwynarski K; Whittaker S; McMillan A;
Br J Haematol; 2011 May; 153(4):451-85. PubMed ID: 21480860
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2008 Feb; 35(2):197-202. PubMed ID: 18190445
[TBL] [Abstract][Full Text] [Related]
23. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
24. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene.
Schildhaus HU; Cavlar T; Binot E; Büttner R; Wardelmann E; Merkelbach-Bruse S
J Pathol; 2008 Oct; 216(2):176-82. PubMed ID: 18686281
[TBL] [Abstract][Full Text] [Related]
26. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
29. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma.
Yasuda H; Sugimoto K; Imai H; Isobe Y; Sasaki M; Kojima Y; Nakamura S; Oshimi K
Eur J Haematol; 2009 Jan; 82(1):39-45. PubMed ID: 18778369
[TBL] [Abstract][Full Text] [Related]
30. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
31. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
33. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
34. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations.
Costello R; Sanchez C; Le Treut T; Rihet P; Imbert J; Sébahoun G
Br J Haematol; 2010 Jul; 150(1):21-7. PubMed ID: 19912218
[TBL] [Abstract][Full Text] [Related]
36. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
37. NK-cell intravascular lymphomatosis--a mini-review.
Nakamichi N; Fukuhara S; Aozasa K; Morii E
Eur J Haematol; 2008 Jul; 81(1):1-7. PubMed ID: 18462254
[TBL] [Abstract][Full Text] [Related]
38. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
39. EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma.
Hsieh PP; Tung CL; Chan AB; Liao JB; Wang JS; Tseng HH; Su HH; Chang KC; Chang CC
Am J Clin Pathol; 2007 Oct; 128(4):579-84. PubMed ID: 17875508
[TBL] [Abstract][Full Text] [Related]
40. Analysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis.
Ren YL; Nong L; Zhang S; Zhao J; Zhang XM; Li T
Am J Clin Pathol; 2012 Sep; 138(3):435-47. PubMed ID: 22912362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
